Asset Details
Do you wish to reserve the book?
Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
Do you wish to request the book?
Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
2022
Overview
The rapid rollout of vaccines against COVID-19 as a key mitigation strategy to end the global pandemic might be informed by lessons learned from rubella vaccine implementation in response to the global rubella epidemic of 1963-1965. That rubella epidemic led to the development of a rubella vaccine that has been introduced in all but 21 countries worldwide and has led to elimination of rubella in 93 countries. Although widespread introduction and use of rubella vaccines was slower than that for COVID-19 vaccines, the process can provide valuable insights for the continued battle against COVID-19. Experiences from the rubella disease control program highlight the critical and evolving elements of a vaccination program, including clearly delineated goals and strategies, regular data-driven revisions to the program based on disease and vaccine safety surveillance, and evaluations to identify the vaccine most capable of achieving disease control targets.
Publisher
Centers for Disease Control and Prevention
Subject
/ Babies
/ Clinical and Health Services Delivery and Impact
/ COVID-19
/ COVID-19 - prevention & control
/ Humans
/ LDCs
/ Measles
/ Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
/ Rubella
/ Rubella - prevention & control
/ Severe acute respiratory syndrome coronavirus 2
/ Vaccines
/ Viruses
